Non-Surgical Lumpectomy Technique Under Investigation at UC Davis Cancer Center
CONTACT: Claudia Morain
Pager: (916) 762-9855
(SACRAMENTO, Calif.) -- An experimental technique that destroys breast cancer cells without surgery is under evaluation at UC Davis Cancer Center. Instead of cutting out a tumor, the experimental technique uses radio wave energy to kill cancer cells deep inside the breast.
Vijay Khatri, assistant professor of surgery at UC Davis Cancer Center, John McGahan, professor of radiology, and Bijan Bijan, assistant professor of radiology, are leading a pilot study to evaluate the technique’s effectiveness. The investigators are ready to enroll about 30 Sacramento-area women with very small, early stage breast tumors in the study.
Because the technique is experimental, all of the women will undergo a conventional lumpectomy or mastectomy following the radio wave treatment. After this conventional surgery, researchers will carefully examine the excised breast tissue to confirm that all cancer was eradicated by the radio wave treatment.
If the pilot trial finds radio wave treatment to be effective in killing the tumor cells, the technique could offer advantages over lumpectomy. “There are two potential advantages of the new technique,” Khatri said. “First, you don’t have to make a big incision. Second, you kill only the tumor and a very thin layer of tissue surrounding it. In a lumpectomy, you take out much more tissue. So the cosmetic results should be much better.”
Khatri, McGahan and Bijan received a $90,000 grant from the UC Davis Health System to carry out the study.
Radio wave therapy, also known as radiofrequency ablation, has been used for many years to treat liver and bone cancers at UC Davis and other centers. And some researchers around the country are studying the therapy as a treatment for lung and prostate cancers.
But radio wave therapy is showing particular potential in breast cancer. Over the last few years, the therapy has been tested in a small number of breast cancer patients at Stanford University, the University of Texas M.D. Anderson Cancer Center in Houston, and the Weill Cornell Breast Center in New York, all with favorable results.
To perform radiofrequency ablation, doctors first locate the tumor using ultrasound. Next a thin metal probe is introduced into the tumor through the skin. Tiny wires at the tip of the probe vibrate, generating a frictional heat that kills all of the cells touched by the probe. Patients walk away after the procedure with only a tiny cut visible on the skin. The killed cancer cells eventually form a scar inside the breast.
Other breast cancer research currently underway at UC Davis Cancer Center includes:
*a trial of a minimally invasive probe that uses light and electrical current to immediately assess malignancy in suspicious breast lesions, potentially eliminating the need for biopsy;
*a digital mammography trial, comparing the accuracy of digital to standard film mammography;
*and a sentinel node biopsy study that explores the safety and effectiveness of removing only one lymph node for biopsy in women with breast cancer. Standard practice has been to remove a dozen or more lymph nodes to determine if cancer has spread.
UC Davis Cancer Center, a program of the University of California, Davis, is a nationally recognized research and treatment center at the front line of the war against cancer. With more than 209 scientists engaged in cancer research and treatment and more than $32 million in cancer research funding, the center is able to offer patients the most advanced therapies--and consequently the greatest hope for recovery.
Copies of all news releases from UC Davis Health System are available here.